Even when trial results are formally negative, they are often presented in a not-negative way during oral presentations at medical conferences, according to a research letter published in JAMA Oncology.

In this quality improvement analysis, researchers reviewed oral presentations of phase 3 randomized clinical trials presented at the American Society of Clinical Oncology and European Society for Medical Oncology congresses from 2017 through 2019.

Formally negative trials were classified according to the reasons of not-negative conclusions:  numerically better…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.